200195-19-3

Basic information

• Product Name: 3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE
• Synonyms: 3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE;3-Oxo-3,4-dihydro-2H-benzo[1,4]oxazine-7-carbaldehyde;3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7- carbaldehyde;3-oxo-4H-1,4-benzoxazine-7-carbaldehyde
• CAS NO: 200195-19-3
• Molecular Formula: C₉H₇NO₃
• Molecular Weight: 177.158
• Mol File: 200195-19-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE(200195-19-3)
• EPA Substance Registry System: 3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE(200195-19-3)

Safety Data

• Hazardous Substances Data: 200195-19-3(Hazardous Substances Data)

Usage

Description

3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE is a complex chemical compound characterized by a benzoxazine ring with a carbaldehyde group attached, a keto group at the 3-position, and a dihydro functionality at the 3,4-positions. This unique structure and reactivity make it a promising candidate for applications in organic synthesis and pharmaceutical research.
Used in Organic Synthesis:
3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE is used as a building block for the synthesis of more complex organic molecules. Its unique structure allows for the creation of a variety of compounds with different properties and potential applications.
Used in Pharmaceutical Research:
3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE is used as a precursor for the development of new drugs. Its reactivity and unique structure make it a valuable component in the design and synthesis of novel pharmaceutical compounds.
Further research and testing are necessary to fully understand the properties and potential uses of 3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE, as its applications in different industries may vary.

Upstream product

• 142166-00-5 methyl 3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylate 
• 713-52-0 methyl 3-hydroxy-4-nitrobenzoate 
• 253687-16-0 7-(hydroxymethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one 
• 200195-17-1 2-chloro-N-(4-[1,3]dioxan-2-yl-2-hydroxy-phenyl)-acetamide 
• 704-13-2 5-formyl-2-nitrophenol 
• 852233-77-3 ethyl 2-(5-formyl-2-nitrophenoxy)acetate 
• 200195-14-8 4-(chloroacetyl-amino)-3-hydroxy-benzaldehyde 
• 200195-16-0 2-(3-hydroxy-4-nitro-phenyl)-1,3-dioxane 

Downstream Products

• 200195-01-3 7-[4-(4-Chloro-phenyl)-piperazin-1-ylmethyl]-4H-benzo[1,4]oxazin-3-one 
• 253687-19-3 7-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-4H-benz[1,4]oxazin-3-one 
• 853657-91-7 diethyl (2S)-2-{[(2S)-2-({[4-(4-cyanobenzyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl]methyl}amino)-3-phenylpropanoyl]amino}pentanedioate 
• 852233-71-7 ethyl (2S)-2-({[4-(4-cyanobenzyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl]methyl}-amino)-3-phenylpropanoate 
• 853657-90-6 (2S)-2-({[4-(4-cyanobenzyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl]methyl}amino)-3-phenyl-propanoic acid 
• 852233-78-4 4-[(7-formyl-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)methyl]-benzonitrile 

Relevant articles and documents

SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES

The invention provides compounds represented by the structural formula (1): wherein R1, R2, R3, R4, R5, R6 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.

Toward a novel class of antithrombotic compounds with dual function. Discovery of 1,4-benzoxazin-3(4H)-one derivatives possessing thrombin inhibitory and fibrinogen receptor antagonistic activities

A novel class of potential antithrombotic compounds with moderate thrombin inhibitory and fibrinogen receptor antagonistic activity is described. Combination of anticoagulant and antiaggregatory activity in the same molecular entity is presented as a new

Benzoxazinone dopamine D4 receptor antagonists

This invention relates to compounds that are antagonists of dopamine D4 receptors, to methods of treating psychosis and schizophrenia using a compound that is an antagonist of dopamine D4 receptors, and to pharmaceutically acceptable compositions that con